|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Department of Medicine (Drs. Han and Strohl), Louis Stokes VA Medical Center, Case Western Reserve University, Cleveland, OH; and the Department of Medicine (Drs. Chen, He, and Ding, and Ms. Wei), Peoples Hospital, Medical School of Beijing University, Beijing, China.
Correspondence to: Kingman P. Strohl, MD, FCCP, VAMC 111j(w), 10701 East Blvd, Cleveland OH 44106; e-mail: KPSTROHL{at}aol.com
Objectives: This study was designed to examine respiratory control in patients with obstructive sleep apnea-hypopnea syndrome (OSAHS), with or without CO2 retention.
Methods: We recruited 10 body mass index-matched,
apnea-hypopnea index-matched, age-matched, and lung function-matched
OSAHS patients, according to their awake PaCO2.
Five patients were hypercapnic (PaCO2,
45
mm Hg), and five patients were eucapnic. Hypoxic responses (the ratio
of the change in minute ventilation [
E] to the
change in arterial oxygen saturation
[
SaO2] and the ratio of the change in
mouth occlusion pressure over the first 100 ms of inspiration against
an occluded airway [
P0.1] to
SaO2) and hypercapnic responses
(
E/
PCO2 ratio and
P0.1/
PCO2 ratio) were tested
during wakefulness before treatment in all 10 patients, and before and
during treatment (at 2, 4, and 6 weeks) with pressure support in the
hypercapnic group.
Results: Hypercapnic
patients had lower mean (± SD)

E/
SaO2 ratio than
eucapnic patients (-0.17 ± 0.04 vs -0.34 ± 0.04
L /min/%SaO2, respectively), lower mean
P0.1/
SaO2 ratio
(-0.04 ± 0.02 vs -0.14 ± 0.03 cm
H2O/%SaO2, respectively), and
lower
P0.1/
PCO2 ratio
(0.23 ± 0.1 vs 0.49 ± 0.1 cm H2O/mm Hg, respectively)
[p < 0.05]. After receiving noninvasive ventilation treatment, the
hypercapnic and hypoxic responses of the hypercapnic patients
increased. At 4 to 6 weeks, values for both responses had increased to
within the normal range and PaCO2 had fallen to
< 45 mm Hg, while weight was unchanged.
Conclusions: Depressed chemoresponsiveness plays a role that is independent of obesity in the development of CO2 retention in some OSAHS patients, and it may be a response to sleep-disordered breathing.
Key Words: CO2 retention obstructive sleep apnea-hypopnea syndrome respiratory control
This article has been cited by other articles:
![]() |
N. Kawata, K. Tatsumi, J. Terada, Y. Tada, N. Tanabe, Y. Takiguchi, and T. Kuriyama Daytime Hypercapnia in Obstructive Sleep Apnea Syndrome Chest, December 1, 2007; 132(6): 1832 - 1838. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Mokhlesi and A. Tulaimat Recent Advances in Obesity Hypoventilation Syndrome Chest, October 1, 2007; 132(4): 1322 - 1336. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-P. Laaban, E. Chailleux, and for the Observatory Group of ANTADIR Daytime Hypercapnia in Adult Patients With Obstructive Sleep Apnea Syndrome in France, Before Initiating Nocturnal Nasal Continuous Positive Airway Pressure Therapy Chest, March 1, 2005; 127(3): 710 - 715. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Ayappa, K. I. Berger, R. G. Norman, B. W. Oppenheimer, D. M. Rapoport, and R. M. Goldring Hypercapnia and Ventilatory Periodicity in Obstructive Sleep Apnea Syndrome Am. J. Respir. Crit. Care Med., October 15, 2002; 166(8): 1112 - 1115. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |